INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 99 filers reported holding INSTIL BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $121,097 | -1.1% | 282,938 | +27.3% | 0.00% | – |
| Q2 2023 | $122,472 | +197.3% | 222,272 | +256.6% | 0.00% | – |
| Q1 2023 | $41,190 | -88.4% | 62,333 | -88.9% | 0.00% | -100.0% |
| Q4 2022 | $354,519 | +354.5% | 562,728 | +3243.8% | 0.00% | – |
| Q2 2022 | $78,000 | -67.5% | 16,829 | +75.9% | 0.00% | -100.0% |
| Q1 2021 | $240,000 | – | 9,568 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Curative Ventures V LLC | 37,980,073 | $16,255,471 | 100.00% |
| CPMG Inc | 8,218,467 | $3,517,504 | 1.92% |
| Western Standard LLC | 1,796,987 | $769,110 | 0.70% |
| Vivo Capital, LLC | 12,486,787 | $5,344,345 | 0.59% |
| Nantahala Capital Management | 1,000,000 | $428,000 | 0.04% |
| Baker Brothers Advisors | 4,704,395 | $2,013,481 | 0.01% |
| HCR Wealth Advisors | 40,000 | $17,120 | 0.00% |
| Hennion & Walsh Asset Management, Inc. | 98,080 | $41,978 | 0.00% |
| Long Focus Capital Management, LLC | 100,000 | $42,800 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 867,279 | $371,195 | 0.00% |